NASDAQ: CAI
Caris Life Sciences Inc Stock Ownership - Who owns Caris Life Sciences?

Insider buying vs selling

Have Caris Life Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
George PosteDirector2026-05-291,600$15.62
$24.99kBuy
Jonathan Kenneth Charles KnowlesDirector2026-05-291,600$15.62
$24.99kBuy
David Baxley SpetzlerPresident2026-05-1513,856$15.25
$211.30kSell
David D. HalbertFounder Chairman and Chief Executive Officer2026-05-1540,712$15.25
$620.86kSell
John Russel DentonSenior Vice President General Counsel and Secretary2026-05-156,047$15.25
$92.22kSell
Luke Thomas PowerSenior Vice President Chief Financial Officer and Chief Accounting Officer2026-05-159,771$15.25
$149.01kSell
Brian J. BrilleVice Chairman and Executive Vice President2026-05-1513,987$15.25
$213.30kSell
Jeff L. VacircaDirector2026-05-1131,050$16.15
$501.43kBuy
David Paul FredricksonDirector2026-02-262,492$20.06
$49.99kBuy
Jon HalbertDirector2026-02-262,492$20.06
$49.99kBuy

1 of 3

CAI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CAI insiders and whales buy or sell their stock.

CAI Shareholders

What type of owners hold Caris Life Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
David D. Halbert49.48%139,863,002$2.58BInsider
Fmr LLC10.89%30,785,585$568.61MInstitution
Tssp Subfund Holdco LLC8.63%24,385,399$450.40MInsider
J H Whitney VI L P7.17%20,256,615$374.14MInsider
J H Whitney Equity Partners VI LLC6.46%18,256,615$337.20MInstitution
Adapt I Ltd5.99%16,943,232$312.94MInsider
Sixth Street Partners Management Company LP5.09%14,385,399$265.70MInstitution
Peter M. Castleman3.68%10,395,044$192.00MInsider
Coatue Management LLC3.47%9,819,992$181.38MInstitution
Braidwell LP2.83%8,009,447$147.93MInstitution

1 of 3

CAI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CAI41.85%58.15%Net SellingNet Selling
CRSP69.13%30.87%Net BuyingNet Selling
LEGN25.86%0.15%Net SellingNet Selling
TVTX63.57%36.43%Net SellingNet Selling
XENE97.56%2.44%Net SellingNet Selling

Caris Life Sciences Stock Ownership FAQ

Who owns Caris Life Sciences?

Caris Life Sciences (NASDAQ: CAI) is owned by 55.49% institutional shareholders, 77.10% Caris Life Sciences insiders, and 0.00% retail investors. David D. Halbert is the largest individual Caris Life Sciences shareholder, owning 139.86M shares representing 49.48% of the company. David D. Halbert's Caris Life Sciences shares are currently valued at $2.58B.

If you're new to stock investing, here's how to buy Caris Life Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.